Stock EVT EVOTEC SE
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Evotec SE

Equities

EVT

DE0005664809

Market Closed - Xetra
Other stock markets
 11:35:07 2024-05-16 am EDT 		5-day change 1st Jan Change
10.27 EUR -2.00% Intraday chart for Evotec SE +6.48% -51.74%
May. 14 Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment MT
May. 14 Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE to announce results for first quarter 2024 on 22 may 2024
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system.
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec : Information on agenda item 4 “Appointment of the auditor, the Group auditor for the 2024 financial year and the auditor for the review of additional interim financial information”,
PU
Evotec : Remuneration report 2023 on agenda item 5,
PU
Evotec : Convening and Agenda of the Annual General Meeting,
PU
Evotec : Company Presentation 2.985 MB
PU
Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212,
PU
Evotec : Revocation of proxy,
PU
Evotec : partner Kazia reports the successful completion of the EVT801 Phase 1 clinical trial in advanced cancer patients
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVT Stock
  4. News Evotec SE
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW